REFAT BARIDI MD NPI 1285622621

NPI Information

  • NPI: 1285622621
  • Provider Name: REFAT BARIDI, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 7425 JANES AVE
    WOODRIDGE, IL
    ZIP 60517
  • Phone: (815) 300-7764

Map and Directions

Get Directions

NPI Details

Refat Baridi, MD is a hematology and oncology internal medicine in Woodridge, IL with 39 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Refat Baridi, MD NPI is 1285622621. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

7425 JANES AVE
WOODRIDGE, IL
ZIP 60517-356
Phone: (815) 300-7764

The NPI 1285622621 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
  • Injection, pegfilgrastim-apgf, biosimilar, (nyvepria), 0.5 mg (HCPCS:Q5122)
  • Magnesium level (HCPCS:83735)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, potassium chloride, per 2 meq (HCPCS:J3480)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg (HCPCS:J2916)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection, calcium gluconate, per 10 ml (HCPCS:J0610)
  • Collection of blood sample from implanted device (HCPCS:36591)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Phosphate level (HCPCS:84100)
  • Administration of prolonged chemotherapy into vein (HCPCS:96416)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
  • Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Infusion, albumin (human), 25%, 50 ml (HCPCS:P9047)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Injection, hydrocortisone sodium succinate, up to 100 mg (HCPCS:J1720)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Injection of drug or substance into vein (HCPCS:96374)

The enumeration date for this NPI number is 10/10/2005 and was last updated on 1/10/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology036087412ILLINOISYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1830007376OTHERILLINOISRAILROAD MEDICARE
2036087412MEDICAIDILLINOIS
3IL3596017OTHERILLINOISLOCALITY 15 PTAN

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.